# Rapid Point of Care Test to Quantify HIV Drugs for Adherence Monitoring

> **NIH NIH N43** · ZYMERON CORPORATION · 2021 · $299,988

## Abstract

The goal is to develop novel, low-cost, real-time point-of-care (POC) assays for antiretroviral drug adherence monitoring:
- Rapid point-of-care methods that measure long-term (> 7 days) adherence to antiretroviral drugs
- Ability to measure drug levels in various biological matrices, e.g., urine, hair, dried blood spots, etc.
- Ability to monitor PrEP adherence, ART adherence to trigger adherence interventions, the long-tail associated with long-acting ART or PrEP, and blood donations for PrEP or ART drug levels (as a risk indicator of HIV exposure or infection)

## Key facts

- **NIH application ID:** 10439549
- **Project number:** 75N93021C00030-0-9999-1
- **Recipient organization:** ZYMERON CORPORATION
- **Principal Investigator:** JASON ZHOU
- **Activity code:** N43 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2021
- **Award amount:** $299,988
- **Award type:** —
- **Project period:** 2021-07-01 → 2022-06-30

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10439549

## Citation

> US National Institutes of Health, RePORTER application 10439549, Rapid Point of Care Test to Quantify HIV Drugs for Adherence Monitoring (75N93021C00030-0-9999-1). Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/grant/nih/10439549. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*